Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP-compliance OECD guideline study, available as unpublished report, no restrictions, adequate for assessment.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Deviations:
yes
Remarks:
Test substance characterisation and stability data not developed in accordance with the standard
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium dibenzyldithiocarbamate
EC Number:
259-587-9
EC Name:
Sodium dibenzyldithiocarbamate
Cas Number:
55310-46-8
Molecular formula:
C15H15NS2.Na
IUPAC Name:
sodium (dibenzylcarbamothioyl)sulfanide

Test animals / tissue source

Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Ranch Rabbits, Crawley Down, Sussex, England.
- Age at study initiation: 4 months old
- Weight at study initiation: 3.80 kg
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 6 weeks

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22°C
- Humidity (%): 49-53% R.H.
- Air changes: 15 complete air changes per hour without re-circulation
- Photoperiod: 12 hrs dark / 12 hrs artificial light

IN-LIFE DATES: To: 12 May 1992

Test system

Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent no treatment
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 g
Observation period (in vivo):
Animal observed for several minutes immediately following distillation, twice during the first hour after dosing and at regular interval throughout the day and daily.
Occular reaction assessed 1, 24, 48 and 72 hours and 7, 14 and 21 days after treatment.
Number of animals or in vitro replicates:
1 male
Details on study design:
TOOL USED TO ASSESS SCORE: fluorescein

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
cornea opacity score
Basis:
mean
Time point:
other: 24, 48 and 72 hours
Score:
1
Max. score:
4
Reversibility:
fully reversible within: 14 days
Remarks on result:
other: The results are applicable for 16.9% aqueous solution of the substance. An ulceration of the cornea observed on Day 21 was unlikely to have reflected an effect of Perkacit SBEC
Irritation parameter:
iris score
Basis:
mean
Time point:
other: 24, 48 and 72 hours
Score:
1
Max. score:
2
Reversibility:
fully reversible within: 7 days
Remarks on result:
other: The results are applicable for 16.9% aqueous solution of the substance.
Irritation parameter:
conjunctivae score
Basis:
mean
Time point:
other: 24, 48 and 72 hours
Score:
2
Max. score:
3
Reversibility:
not fully reversible within: 21 days
Remarks on result:
other: The results are applicable for 16.9% aqueous solution of the substance.
Irritation parameter:
chemosis score
Basis:
mean
Time point:
other: 24, 48 and 72 hours
Score:
1
Max. score:
4
Reversibility:
fully reversible within: 7 days
Remarks on result:
other: The results are applicable for 16.9% aqueous solution of the substance.
Irritant / corrosive response data:
A diffuse crimson-red appearance to the conjunctiva, very slight chemosis and a substantial discharge were evident throughout the first 72 hours following instillation. Slight opacity, covering up to the entire corneal surface, and iritis were observed at this time.
At the end of the first week of observation, injection of the conjunctival blood vessels and slight corneal opacity persisted; the opacity resolved by the fourteenth day after treatment, but the conjunctival change persisted to termination.
Other effects:
Instillation of the test material caused a moderate initial pain response.

Applicant's summary and conclusion